AstraZeneca Stock Tanks Over Expiring Patents & Weak Results
January 31, 2013 - 10:01am
The stock price of AstraZeneca (ADR) (NYSE:AZN) declined by more than 5 percent in pre-market trading Thursday after the Anglo-Swedish pharmaceutical company warned investors that of its expiring patents and reported a decline in net profits for the year 2o12.…The post AstraZeneca Stock Tanks Over Expiring Patents & Weak Results appeared first on ValueWalk.
Continue reading this article »
Share This Article: